- Home
- BCTX vs MODV Comparison
BCTX vs MODV Comparison
Compare BCTX & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- MODV
- Stock Information
- Founded
- BCTX 2014
- MODV 1996
- Country
- BCTX Canada
- MODV United States
- Employees
- BCTX N/A
- MODV N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- BCTX Health Care
- MODV Consumer Discretionary
- Exchange
- BCTX Nasdaq
- MODV Nasdaq
- Market Cap
- BCTX 16.1M
- MODV 16.1M
- IPO Year
- BCTX N/A
- MODV N/A
- Fundamental
- Price
- BCTX $3.41
- MODV $1.92
- Analyst Decision
- BCTX Strong Buy
- MODV Buy
- Analyst Count
- BCTX 1
- MODV 4
- Target Price
- BCTX $32.00
- MODV $9.17
- AVG Volume (30 Days)
- BCTX 791.2K
- MODV 7.2M
- Earning Date
- BCTX 06-13-2025
- MODV 05-08-2025
- Dividend Yield
- BCTX N/A
- MODV N/A
- EPS Growth
- BCTX N/A
- MODV N/A
- EPS
- BCTX N/A
- MODV N/A
- Revenue
- BCTX N/A
- MODV $2,753,789,000.00
- Revenue This Year
- BCTX N/A
- MODV N/A
- Revenue Next Year
- BCTX N/A
- MODV $5.20
- P/E Ratio
- BCTX N/A
- MODV N/A
- Revenue Growth
- BCTX N/A
- MODV N/A
- 52 Week Low
- BCTX $2.81
- MODV $0.87
- 52 Week High
- BCTX $29.40
- MODV $32.82
- Technical
- Relative Strength Index (RSI)
- BCTX 47.56
- MODV 63.05
- Support Level
- BCTX $2.81
- MODV $1.07
- Resistance Level
- BCTX $3.69
- MODV $3.48
- Average True Range (ATR)
- BCTX 0.28
- MODV 0.39
- MACD
- BCTX 0.06
- MODV 0.14
- Stochastic Oscillator
- BCTX 65.93
- MODV 40.23
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.